Prediatr., 551-556, 1981
TB-500 is a 43-residue, 4963.4 g/mol thymosin beta 4 sequence acting through G-actin sequestration and integrin-linked kinase signalling, studied mainly in cardiac, corneal, dermal and skeletal muscle models
Jiao H, Wang Z, Liu Y et al
It helps keep the intestinal barrier functioning normally, supports a balanced microbiome, and promotes healthy digestive function.*1-3
Thus, given the initial infarct induction and re-infarction (the myocardial lesions after two isoprenaline applications) and that BPC 157 markedly counteracts myocardial isoprenaline lesions, the findings provide multidirectional evidence [38]
BPC-157 has been shown in vitro to suppress NF-B pathway activation and reduce pro-inflammatory prostaglandin production